Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer via cell-cell communication

Figure 7 Analysis of the tumor mutation burden in the samples. A: The distribution of tumor mutation burden (TMB) for all samples; B and C: Waterfall plots depicting mutation landscapes in the high-risk and low-risk groups, respectively; D-F: A comparative analysis of TMB was conducted in the high-risk and low-risk groups identified by the gene signature identified in this article and the groups identified by the gene signature proposed by Tang et al[11] and Wang et al[12].